Sign in
Taking people in BrazilNo phase

Tests aerobic exercise training in people with Parkinson's disease

Tests a 12-week supervised aerobic exercise program against usual care in adults with Parkinson's.

Key facts

Who runs it
Raphael Mendes Ritti Dias
Where
São Paulo, BrazilSee the site
Trial code
Registry title
Brief Title: Aerobic Training on Cerebrovascular Function, Cognition and Gait in Parkinson's Disease
Status
Recruiting
People taking part
40 people, planned
Started
28 Feb 2026
Expected to end
31 Dec 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Aerobic training
  • Usual Care
Record updated
13 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with Parkinson's disease at stages 1-3 who take stable medication and can walk on their own. It tests a 12-week supervised aerobic training program against usual care.

Age
40 years and older
Sex
Men and women can join.
Disease stage
Clinical diagnosis of Parkinson's disease, Hoehn & Yahr stages 1-3.
Earlier treatment
Stable antiparkinsonian medication for at least 4 weeks.
Biomarker or test result
Montreal Cognitive Assessment (MoCA) score of 18 or higher.

Main reasons for not taking part

  • A change in medication
  • A contraindication to exercise
  • Cannot walk independently (with or without an assistive device)
  • No medical clearance for moderate-intensity exercise

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Clinical diagnosis of Parkinson's disease
  • Hoehn \& Yahr stages 1-3
  • Stable antiparkinsonian medication for at least 4 weeks
  • Montreal Cognitive Assessment (MoCA) score ≥ 18
  • Ability to walk independently (with or without assistive device)
  • Medical clearance for participation in moderate-intensity exercise

Who cannot take part

  • Change in medication
  • Contraindication to exercise

Where in Brazil

  • Associação Brasil ParkinsonSão Paulo, BrazilContact: Verônica Souza, MDTaking people

About the trial

What the trial wants to find out

This randomized controlled trial will investigate the effects of a 12-week supervised aerobic training program on cerebrovascular function, peripheral vascular health, cardiovascular autonomic modulation, cognition, non-motor symptoms, sleep, mood, gait biomechanics, quality of life, and body composition in patients with Parkinson's disease (Hoehn \& Yahr stages 1-3). Participants will be randomly allocated to aerobic training or usual care.

The 2 groups in the trial

  • Aerobic TrainingTreatment being tested

    Participants will perform supervised aerobic training on a cycle ergometer, 3 times per week for 12 weeks, 40 minutes per session, at perceived exertion 12-13 on Borg scale.

  • Usual CareOther group

    Participants will maintain their usual clinical care and daily activities without structured exercise intervention.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Effects of Aerobic Training on Cerebrovascular Function, Cognitive Performance and Gait Parameters in Patients With Parkinson's Disease: A Randomized Controlled Trial
Plain-language title
Tests aerobic exercise training in people with Parkinson's diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
13 April 2026